The Impact of hyperuricemia on long-term clinical outcomes of renal transplant recipients: a systematic review and meta-analysis

Purpose: To evaluate the effect of hyperuricemia on clinical outcomes of renal transplant recipients (RTRs). Methods: A literature search of PubMed, Cochrane, Embase was conducted up to March 20, 2020. The primary outcome was the estimated glomerular filtration rate (eGFR). The second outcomes were...

Full description

Bibliographic Details
Main Authors: hui Yang, Qing Chen, Aiwen Huang, Xiaojia Yu, Gang Chen, Xiaopeng Hu, Wei Wang, Hang Liu, Xiaodong Zhang, Lihong Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Journal of Pharmacy & Pharmaceutical Sciences
Online Access:https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/31620
_version_ 1797763274931961856
author hui Yang
Qing Chen
Aiwen Huang
Xiaojia Yu
Gang Chen
Xiaopeng Hu
Wei Wang
Hang Liu
Xiaodong Zhang
Lihong Liu
author_facet hui Yang
Qing Chen
Aiwen Huang
Xiaojia Yu
Gang Chen
Xiaopeng Hu
Wei Wang
Hang Liu
Xiaodong Zhang
Lihong Liu
author_sort hui Yang
collection DOAJ
description Purpose: To evaluate the effect of hyperuricemia on clinical outcomes of renal transplant recipients (RTRs). Methods: A literature search of PubMed, Cochrane, Embase was conducted up to March 20, 2020. The primary outcome was the estimated glomerular filtration rate (eGFR). The second outcomes were the risk of graft loss, death, cardiovascular event and the level of triglyceride. The following search terms were utilized: ((Hyperuricemic group) OR (Hyperuricaemia) OR (Hyperuric) OR (Urea acid) OR (Uric acid) OR (Acid urate) OR (Urate) OR (Gout)) and ((Transplantation) OR (Transplantations) OR (Transplant) OR (Transplants) OR (Graft)). Results: 28 studies with 18224 patients were eligible for inclusion. There was no significant difference in eGFR (<12 months, p=0.07), the risk of graft loss (<60 months, p=0.07) and death (<60months, p=0.19) between the hyperuricemic and normouricemic group in the early post-transplantation period. But increased uric acid levels contributed to the long-term decline of eGFR, the risk of graft loss and death increased after transplantation. Hyperuricemia increased the risk of cardiovascular event with no significant difference in the level of triglyceride between the two groups. Conclusions: Increased uric acid levels contributed to the long-term decline of eGFR, increased risk of graft loss and death after transplantation. Although there was no significant effect on triglyceride, hyperuricemia increased the risk of cardiovascular event.
first_indexed 2024-03-12T19:40:14Z
format Article
id doaj.art-4c8492cf06f3421b8d652156ab14d403
institution Directory Open Access Journal
issn 1482-1826
language English
last_indexed 2024-03-12T19:40:14Z
publishDate 2021-06-01
publisher Frontiers Media S.A.
record_format Article
series Journal of Pharmacy & Pharmaceutical Sciences
spelling doaj.art-4c8492cf06f3421b8d652156ab14d4032023-08-02T03:54:20ZengFrontiers Media S.A.Journal of Pharmacy & Pharmaceutical Sciences1482-18262021-06-0124310.18433/jpps31620The Impact of hyperuricemia on long-term clinical outcomes of renal transplant recipients: a systematic review and meta-analysishui YangQing ChenAiwen HuangXiaojia YuGang ChenXiaopeng HuWei WangHang LiuXiaodong ZhangLihong LiuPurpose: To evaluate the effect of hyperuricemia on clinical outcomes of renal transplant recipients (RTRs). Methods: A literature search of PubMed, Cochrane, Embase was conducted up to March 20, 2020. The primary outcome was the estimated glomerular filtration rate (eGFR). The second outcomes were the risk of graft loss, death, cardiovascular event and the level of triglyceride. The following search terms were utilized: ((Hyperuricemic group) OR (Hyperuricaemia) OR (Hyperuric) OR (Urea acid) OR (Uric acid) OR (Acid urate) OR (Urate) OR (Gout)) and ((Transplantation) OR (Transplantations) OR (Transplant) OR (Transplants) OR (Graft)). Results: 28 studies with 18224 patients were eligible for inclusion. There was no significant difference in eGFR (<12 months, p=0.07), the risk of graft loss (<60 months, p=0.07) and death (<60months, p=0.19) between the hyperuricemic and normouricemic group in the early post-transplantation period. But increased uric acid levels contributed to the long-term decline of eGFR, the risk of graft loss and death increased after transplantation. Hyperuricemia increased the risk of cardiovascular event with no significant difference in the level of triglyceride between the two groups. Conclusions: Increased uric acid levels contributed to the long-term decline of eGFR, increased risk of graft loss and death after transplantation. Although there was no significant effect on triglyceride, hyperuricemia increased the risk of cardiovascular event.https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/31620
spellingShingle hui Yang
Qing Chen
Aiwen Huang
Xiaojia Yu
Gang Chen
Xiaopeng Hu
Wei Wang
Hang Liu
Xiaodong Zhang
Lihong Liu
The Impact of hyperuricemia on long-term clinical outcomes of renal transplant recipients: a systematic review and meta-analysis
Journal of Pharmacy & Pharmaceutical Sciences
title The Impact of hyperuricemia on long-term clinical outcomes of renal transplant recipients: a systematic review and meta-analysis
title_full The Impact of hyperuricemia on long-term clinical outcomes of renal transplant recipients: a systematic review and meta-analysis
title_fullStr The Impact of hyperuricemia on long-term clinical outcomes of renal transplant recipients: a systematic review and meta-analysis
title_full_unstemmed The Impact of hyperuricemia on long-term clinical outcomes of renal transplant recipients: a systematic review and meta-analysis
title_short The Impact of hyperuricemia on long-term clinical outcomes of renal transplant recipients: a systematic review and meta-analysis
title_sort impact of hyperuricemia on long term clinical outcomes of renal transplant recipients a systematic review and meta analysis
url https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/31620
work_keys_str_mv AT huiyang theimpactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis
AT qingchen theimpactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis
AT aiwenhuang theimpactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis
AT xiaojiayu theimpactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis
AT gangchen theimpactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis
AT xiaopenghu theimpactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis
AT weiwang theimpactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis
AT hangliu theimpactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis
AT xiaodongzhang theimpactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis
AT lihongliu theimpactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis
AT huiyang impactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis
AT qingchen impactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis
AT aiwenhuang impactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis
AT xiaojiayu impactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis
AT gangchen impactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis
AT xiaopenghu impactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis
AT weiwang impactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis
AT hangliu impactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis
AT xiaodongzhang impactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis
AT lihongliu impactofhyperuricemiaonlongtermclinicaloutcomesofrenaltransplantrecipientsasystematicreviewandmetaanalysis